Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for AbbVie
Company Monitoring Page for AbbVie
latest headlines for company on cafepharma
Biosimilar makers split strategies in bid to take on top-selling Humira
BioPharma Dive
Thu, 07/27/23 - 10:25 am
Tags:
biosimilars
,
Humira
,
AbbVie
,
rebates
,
drug pricing
,
Amgen
,
Celltrion
,
Novartis
,
Boehringer Ingelheim
,
Biocon
,
Fresenius
,
Sandoz
,
Organon
,
Coherus
AbbVie's Skyrizi delivers head-to-head win versus Amgen's Otezla in psoriasis
Fierce Pharma
Wed, 07/26/23 - 11:37 am
Tags:
AbbVie
,
Skyrizi
,
Amgen
,
Otezla
,
Boehringer Ingelheim
,
psoriasis
Teva expands Alvotech collab with 2 more biosims, increased manufacturing oversight and a $40M investment
Fierce Pharma
Mon, 07/24/23 - 09:35 pm
Tags:
Teva Pharmaceutical
,
Alvotech
,
biosimilars
,
Humira
,
AbbVie
,
drug manufacturing
Companies to Watch: 12 Late-Stage Contenders in Neurodegenerative Disease
BioSpace
Mon, 07/24/23 - 09:57 am
Tags:
neurodegenerative disease
,
Alzheimer's disease
,
Axsome Therapeutics
,
Eli Lilly
,
Anavex
,
TauRx
,
AB Science
,
ALS
,
BrainStorm Cell Therapeutics
,
Seelos Therapeutics
,
Parkinson's Disease
,
AbbVie
,
Mitsubishi Tanabe Pharma
,
Annovis
,
Huntington's disease
,
Prilenia Therapeutics
,
Neurocrine
Check out the most-seen pharma brand TV debuts of 2023
Medical Marketing and Media
Wed, 07/19/23 - 05:49 pm
Tags:
TV ads
,
DTC advertising
,
Bayer
,
AbbVie
,
Bristol Myers Squibb
Four Crucial Questions about the Humira Biosimilar Price War
Drug Channels
Tue, 07/18/23 - 11:38 am
Tags:
AbbVie
,
Humira
,
biosimilars
AbbVie, Lilly-backed Capsida cuts staff months after signing Big Pharma deals
Fierce Biotech
Sun, 07/16/23 - 02:37 pm
Tags:
Capsida Biotherapeutics
,
layoffs
,
gene therapy
,
AbbVie
,
Eli Lilly
Gut punch: First Wave's challenger to AbbVie fails phase 2 again
Fierce Biotech
Thu, 07/13/23 - 10:18 am
Tags:
First Wave Biopharma
,
AbbVie
,
clinical trials
,
Creon
7 companies are rolling out Humira biosimilars
Drugstore News
Wed, 07/12/23 - 09:44 am
Tags:
AbbVie
,
Humira
,
biosimilars
,
Boehringer Ingelheim
,
Organon
,
Samsung Bioepsis
,
Sandoz
,
Fresenius Kabi
,
Celltrion
,
Coherus Biosciences
,
Biocon
Mark Cuban's online pharmacy set to launch Humira biosimilar
Reuters
Fri, 07/7/23 - 06:53 am
Tags:
biosimilars
,
Mark Cuban
,
Mark Cuban Cost Plus Drugs
,
AbbVie
,
Humira
,
Coherus Biosciences
Revance wants you to 'Break Up With Botox' as it goes to war with AbbVie in new anti-wrinkle market battle
Fierce Pharma
Mon, 07/3/23 - 10:44 am
Tags:
Revance Therapeutics
,
Daxxify
,
pharma marketing
,
AbbVie
,
Botox
Alvotech to raise cash after third FDA rejection for Humira biosimilar
BioPharma Dive
Fri, 06/30/23 - 11:39 am
Tags:
Alvotech
,
Teva Pharmaceutical
,
AbbVie
,
Humira
,
biosimilars
,
FDA
AbbVie, Genmab Bi-Specific Lymphoma Data Tee Up Potential Challenge to Roche Drug
BioSpace
Thu, 06/29/23 - 11:15 pm
Tags:
AbbVie
,
Genmab
,
Roche
,
follicular lymphoma
,
bispecific antibodies
,
epcoritamab
,
Lunsumio
Genmab and AbbVie plan next steps for Epkinly in follicular lymphoma
Clinical Trials Arena
Wed, 06/28/23 - 10:27 am
Tags:
AbbVie
,
Genmab
,
Epkinly
,
clinical trials
,
relapsed or refractory follicular lymphoma
What Will AbbVie Buy Next?
Motley Fool
Wed, 06/28/23 - 10:01 am
Tags:
AbbVie
,
M&A
,
Blueprint Medicines
,
Krystal Biotech
AbbVie's Imbruvica-Brukinsa patent suit may have merit, and BeiGene will likely settle: expert
Fierce Pharma
Tue, 06/27/23 - 10:21 pm
Tags:
AbbVie
,
patents
,
BeiGene
,
legal
,
Btk inhibitors
AbbVie's Skyrizi posts ulcerative colitis win in maintenance study, teeing up FDA nod
Fierce Pharma
Fri, 06/16/23 - 10:12 am
Tags:
AbbVie
,
ulcerative colitis
,
Skyrizi
,
FDA
AbbVie sues BeiGene over brand-new Imbruvica patent as blood cancer rivalry heats up
Fierce Pharma
Fri, 06/16/23 - 09:44 am
Tags:
AbbVie
,
Pharmacyclics
,
BeiGene
,
Brukinsa
,
patents
,
Imbruvica
,
blood cancer
Coherus breached Humira patent settlement by striking deal with Mark Cuban's drug firm, AbbVie contends
Fierce Pharma
Thu, 06/15/23 - 06:55 pm
Tags:
AbbVie
,
Humira
,
biosimilars
,
Mark Cuban Cost Plus Drugs
,
Coherus Biosciences
Pharma Companies, Pharmacies Agree to Pay $19B in Opioid Settlement
BioSpace
Mon, 06/12/23 - 10:15 am
Tags:
opioids
,
opioid crisis
,
legal
,
pharmacies
,
McKesson
,
AmerisourceBergen
,
Cardinal Health
,
Teva Pharmaceutical
,
AbbVie
,
JNJ
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.